Publication | Closed Access

Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis

Autoimmune DiseaseMedicineImmunologyExperimental Autoimmune EncephalomyelitisReduces InjuryOral TreatmentAutoimmunityBrain-immune InteractionNeurologyNeuroscienceMultiple SclerosisNeuroimmunologyCell TransplantationNeuroinflammation